Diabetes, Dyslipidemia, Hypertension
Conditions
Brief summary
This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the University of Arkansas for Medical Sciences (UAMS) Internal Medicine Clinic North, and the study data will be collected using only subject self-reports and subject pharmacy records.
Interventions
MyMedSchedule is a consumer-grade smartphone application currently available on various marketplaces of the Android and iOS platforms that acts as a portal to the free service MyMedSchedule.com website. It can interface with the MedActionPlan discharge planning tool for providers by automatically populating fields, allowing medication lists to be pushed to a subject's MyMedSchedule account, allowing the input of complex medication regimens, and aiding in medication reconciliation. A MyMedSchedule account can be setup with the patient's name, date of birth, allergies, emergency contact, healthcare providers, insurance plan information, and complete medication list. Medication dose and refill reminders can be set and sent through short message service (SMS) text message or e-mail. SMS text message reminders will be used for this study.
Sponsors
Study design
Eligibility
Inclusion criteria
* Males and females at least 18 years of age * Provide informed consent * Prescribed an oral medication indicated for hypertension, diabetes, or dyslipidemia during 12 weeks pre-enrollment * Own a smartphone (Android or iOS) with unlimited text messaging, email access, and app store access * Oral confirmation that the subject has not previously used a medication adherence app * Able to consult with a pharmacy or medical student during the recruitment process for purposes of consent, data collection, and/or medication reconciliation, and/or MyMedSchedule registration
Exclusion criteria
* Severely impaired vision * Reside in a nursing home * Non-ambulatory/bedridden * Not fluent in English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in number of pills taken over number of pills prescribed at 4 weeks | Change from baseline to 4 weeks |
| Change from baseline in number of pills taken over number of pills prescribed at 12 weeks | Change from baseline to 12 weeks |
Countries
United States